| +974 4003 3333
Ricardo Garcia Branco

Ricardo Garcia Branco 
^ null
MD,FRCPCH,PhD

Attending Physician Years Of Experience: 23

  • About the Physician

    Dr. Branco joined Sidra Medicine in November 2018 as an Attending Physician in the Pediatric Intensive Care Unit (PICU). He Co-chairs the Clinical Effectiveness and Clinical Audit groups at Sidra Medicine.

    Dr. Branco trained in Brazil and the UK, where he obtained a PhD in Pediatrics at the University of Cambridge. He worked as a Consultant in Pediatric Intensive Care at Cambridge University Hospitals from 2011 to 2018.

    He has expertise in Pediatric Critical and Neurocritical care, with a research interest in the stress response to acute and critical illness. Dr. Branco has lectured at multiple international meetings and conferences.

    Languages Spoken

    English, Portuguese, Spanish

    Years Of Experience
    23
    Education
    • Medical doctor (MD), Universidade Federal do Parana, Brazil. 2000
    • Pediatric Residency, Hospital Sao Lucas PUCRS, Brazil. 2003
    • Pediatric Critical Care Residency, Hospital Sao Lucas PIUCRS, Brazil. 2004
    • Pediatric Critical Care Fellowship, Cambridge University Hospitals, UK. 2010
    • Doctor of Philosophy (PhD), University of Cambridge, UK. 2011
    Affiliations
    • Sidra Medicine, Qatar
    Areas of Interest
    • Translational Medicine, Neurocritical care, Genetics of critical illness, Stress response to critical care, Nutrition and Endocrinology of Critical illness, Sepsis
    Educational Interests
    • Postgraduate medical education
    • Supervision of MsC/PhD students
    Medical Publications
    1. Rinchai D, Deola S, Zoppoli G, Kabeer BSA, Taleb S, Pavlovski I, Maacha S, Gentilcore G, Toufiq M, Mathew L, Liu L, Vempalli FR, Mubarak G, Lorenz S, Sivieri I, Cirmena G, Dentone C, Cuccarolo P, Giacobbe DR, Baldi F, Garbarino A, Cigolini B, Cremonesi P, Bedognetti M, Ballestrero A, Bassetti M, Hejblum BP, Augustine T, Van Panhuys N, Thiebaut R, Branco R, Chew T, Shojaei M, Short K, Feng CG; PREDICT-19 Consortium; Zughaier SM, De Maria A, Tang B, Ait Hssain A, Bedognetti D, Grivel JC, Chaussabel D. High-temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines. Sci Adv. 2022 Nov 11;8(45):eabp9961. doi: 10.1126/sciadv.abp9961. Epub 2022 Nov 11. PMID: 36367935; PMCID: PMC9651857.
    2. Zaher S, Branco R, Meyer R, White D, Ridout J, Pathan N. Relationship between inflammation and metabolic regulation of energy expenditure by GLP-1 in critically ill children. Clin Nutr. 2021 Feb;40(2):632-637. doi: 10.1016/j.clnu.2020.06.013.
    3. Rinchai D, Syed Ahamed Kabeer B, Toufiq M, Tatari-Calderone Z, Deola S, Brummaier T, Garand M, Branco R, Baldwin N, Alfaki M, Altman MC, Ballestrero A, Bassetti M, Zoppoli G, De Maria A, Tang B, Bedognetti D, Chaussabel D. A modular framework for the development of targeted Covid-19 blood transcript profiling panels. J Transl Med. 2020 Jul 31;18(1):291. doi: 10.1186/s12967-020-02456-z.
    4. French CE, Delon I, Dolling H, Sanchis-Juan A, Shamardina O, Mégy K, Abbs S, Austin T, Bowdin S, Branco RG, Firth H; NIHR BioResource—Rare Disease; Next Generation Children Project, Rowitch DH, Raymond FL. Whole genome sequencing reveals that genetic conditions are frequent in intensively ill children. Intensive Care Med. 2019 May;45(5):627-636.
    5. Garcia PCR, Barcelos ALM, Tonial CT, Fiori HH, Einloft PR, Costa CAD, Portela JL, Bruno F, Branco RG. Accuracy of cerebrospinal fluid ferritin for purulent meningitis. Arch Dis Child. 2021 Mar;106(3):286-289. doi: 10.1136 /archdischild-2019-317960.